Synonyms: compound 13 [PMID: 36314537] | JNJ64264681
Compound class:
Synthetic organic
Comment: JNJ-64264681 is an orally bioavailable, covalent Bruton's tyrosine kinase (BTK) inhibitor [1].
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
The IC50 of JNJ-64264681's BTK interaction in human B cells is 21 nM [1]. The few kinases that were inhibited by JNJ-64264681 in a kinase profiling screen (BMX, TEC, BLK) have an analogous Cys residue that offers potential for covalent interaction with JNJ-64264681. BTK's rating as primary target was confirmed by kinase selectivity analyses performed in native Ramos B-cell kinome assays. |
Selectivity at enzymes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|